Curtain Call: Perlegen Ceases Operations, Decision Biomarkers Files for Bankruptcy
January 12, 2010
Curtain Call: Perlegen Ceases Operations, Decision Biomarkers Files for Bankruptcy
The demise of Perlegen Sciences and Decision Biomarkers adds two more names to a growing list of array-related firms and businesses that have gone belly up or have been shuttered in the past few years.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mizuho Initiates Coverage of Affymetrix with Outperform Rating
August 26, 2011 / GenomeWeb Daily News - Appeals Court Dismisses Illumina Patent Lawsuit Against Affymetrix
August 19, 2011 / GenomeWeb Daily News - Ariadne to Provide Pathway Analysis Instruction for Affy's Gene Expression Training Program
July 29, 2011 / BioInform - Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index
July 1, 2011 / GenomeWeb Daily News - Team IDs Recurrent NOTCH1 Mutations in CLL Exomes
June 13, 2011 / GenomeWeb Daily News